Equities research analysts expect that athenahealth, Inc (NASDAQ:ATHN) will post earnings of $0.98 per share for the current quarter, Zacks Investment Research reports. Twenty Three analysts have issued estimates for athenahealth’s earnings. The highest EPS estimate is $1.15 and the lowest is $0.87. athenahealth posted earnings per share of $0.56 in the same quarter last year, which suggests a positive year-over-year growth rate of 75%. The business is expected to announce its next earnings report after the market closes on Thursday, November 1st.

According to Zacks, analysts expect that athenahealth will report full-year earnings of $4.19 per share for the current year, with EPS estimates ranging from $3.95 to $4.61. For the next year, analysts anticipate that the business will post earnings of $4.71 per share, with EPS estimates ranging from $4.45 to $5.29. Zacks’ earnings per share calculations are a mean average based on a survey of analysts that cover athenahealth.

athenahealth (NASDAQ:ATHN) last issued its earnings results on Monday, July 30th. The health services provider reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $0.62 by $0.47. The firm had revenue of $323.30 million during the quarter, compared to the consensus estimate of $334.77 million. athenahealth had a net margin of 8.71% and a return on equity of 14.71%. The company’s revenue was up 7.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.51 earnings per share.

A number of equities analysts recently commented on the stock. BidaskClub upgraded shares of athenahealth from a “sell” rating to a “hold” rating in a research note on Wednesday, June 20th. Cowen reissued a “hold” rating and issued a $150.00 price target on shares of athenahealth in a research report on Wednesday, August 1st. Oppenheimer boosted their price target on shares of athenahealth from $158.00 to $179.00 and gave the company an “outperform” rating in a research report on Tuesday, June 19th. Stifel Nicolaus reissued a “hold” rating and issued a $140.00 price target (up from $134.00) on shares of athenahealth in a research report on Tuesday, July 31st. Finally, Leerink Swann set a $140.00 price target on shares of athenahealth and gave the company a “buy” rating in a research report on Friday, September 28th. One analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and eight have issued a buy rating to the company’s stock. athenahealth presently has an average rating of “Hold” and a consensus target price of $152.67.

In other news, insider Daniel P. Haley sold 2,204 shares of the company’s stock in a transaction dated Monday, October 1st. The shares were sold at an average price of $127.23, for a total value of $280,414.92. Following the completion of the sale, the insider now directly owns 10,555 shares of the company’s stock, valued at $1,342,912.65. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders sold 2,654 shares of company stock valued at $345,039 over the last ninety days. Corporate insiders own 2.90% of the company’s stock.

Large investors have recently made changes to their positions in the company. Summit Trail Advisors LLC raised its holdings in shares of athenahealth by 13,481.3% in the first quarter. Summit Trail Advisors LLC now owns 103,218 shares of the health services provider’s stock valued at $103,000 after buying an additional 102,458 shares during the last quarter. Integrated Investment Consultants LLC purchased a new stake in shares of athenahealth in the second quarter valued at about $150,000. Cerebellum GP LLC purchased a new stake in shares of athenahealth in the second quarter valued at about $176,000. Ropes Wealth Advisors LLC purchased a new stake in shares of athenahealth in the second quarter valued at about $194,000. Finally, Campbell & CO Investment Adviser LLC purchased a new stake in shares of athenahealth in the second quarter valued at about $206,000.

Shares of ATHN stock traded up $0.48 on Wednesday, reaching $125.64. 156,875 shares of the stock were exchanged, compared to its average volume of 514,898. The company has a current ratio of 2.62, a quick ratio of 2.62 and a debt-to-equity ratio of 0.23. The company has a market cap of $5.41 billion, a P/E ratio of 80.03, a PEG ratio of 2.36 and a beta of 0.97. athenahealth has a twelve month low of $114.89 and a twelve month high of $163.94.

athenahealth Company Profile

athenahealth, Inc, together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems. It offers athenaCollector, a network-enabled billing and practice management solution; athenaClinicals, an electronic health record for managing patient's clinical documentation; athenaCommunicator, an engagement and communication solution that provides an automated communication service between patients and provider practices for interactions outside the exam room; and athenaCoordinator for order transmission and care coordination services.

Featured Article: Intrinsic Value and Stock Selection

Get a free copy of the Zacks research report on athenahealth (ATHN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.